Navigation Links
Gossypol helps in chemotherapy of neck and head cancer.

Gossypol, a compound present in cottonseed has been found be increase the effectiveness of chemotherapy// for neck and head cancer patients. This could prove beneficial in cancer treatment and help patients worldwide.

Shaomeng Wang, Ph.D., co-director of the Molecular Therapeutics Program at the U-M Comprehensive Cancer Centre, discovered gossypol, a compound derived from a component of Chinese medicine.

"Patients really benefit long-term by avoiding surgery because the side effects of surgery for head and neck cancer can be particularly difficult for patients. It affects how you talk, how you swallow and how you breathe," says study author Carol Bradford, M.D., professor of otolaryngology at the U-M Medical School and co-director of the Head and Neck Oncology Program at the U-M Comprehensive Cancer Centre.

Gossypol, regulates the protein Bcl-xL which is over expressed in cancer cells, as a result the cells are able to survive. Two different cell lines were cultured in the lab and results observed. On the basis of the results the scientists have made this revelation.

Source: Molecular Cancer Therapeutics journal, July issue


'"/>




Page: 1

Related medicine news :

1. Sperm washing helps couples – Breakthrough in focu
2. Patient’s perception of health status helps in better recover
3. New vaccine helps allergy and asthma patients
4. New vaccine helps allergy and asthma patients
5. Now umbilical cord helps in stroke treatment.
6. Spirituality helps lessen arthritic pain
7. New drug helps boost cancer treatment
8. Supplement helps cardiac surgery
9. Antidepressant helps obesity
10. Dopamine helps stroke survivors
11. Radiotherapy helps in colon cancer

Post Your Comments:
(Date:12/4/2009)... Dec. 4 The following i...inz Family Philanthropies: ,, Credit Senators J...gnificant contribution to the health care debate: ...ns living with Phenylketonuria (PKU) control their...rs living with serious chronic conditions are trea...
(Date:12/4/2009)... ischemic stroke are at higher lifetime risk for a... reduce that risk. One of the simplest regimens in... as blood thinners, of which the most common is as...whether the use of antithrombotic medications amon...iod found that in each of the years, approximately...
(Date:12/4/2009)... Tender Corp., a leading manufacturer of over-the...gned to enhance consumers’ quality of life, ...ed American Podiatric Medical Association (APMA) S..., HealthiFeet®. , (P...manufacturer of over-the-counter topical cream and...
(Date:12/4/2009)...Ind., Dec. 4 Hill-Rom Ho...scal 2010 first quarter dividend of $0.1025 per sh...d of Directors on December 3, 2009, and is payable...s of December 17, 2009. ,, ABOUT HILL-ROM ...wide manufacturer and provider of medical technolo...
(Date:12/4/2009)...nn., Dec. 4 MedClean Tec...nnounced the Company has entered into a preferred ..., LLC, a Delaware limited liability company, doin...LLC. Pursuant to the Purchase Agreement, MedClean ... The Company agreed to sell up to 750 shares of it...
Breaking Medicine News(10 mins):Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 2Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 3Health News:Are stroke survivors taking their medicine? 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 3Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 4Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 2Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 3
...y College London and Imperial College London have ...sy environment, such as a pub or in a crowd. // Th...ain work together to make sense of what it hears, ...perience of people who rely on cochlear implants, ...
...tting ready to go home. Savage, who received ...mber last, says he feels sensation in his// new li...and in a ghastly machine press accident. Savag...ansplant surgeries. Savage, who reported sensa...
...r educated about the risks of exposing children to...h researchers.// Results from a 14-year stu...e more likely to suffer respiratory problems. ...rn Australia say the evidence supports a ban on sm...
...ommended a maximum residue limit (MRL) of one part... the panel has suggested that the limit should be ...nsumer safety. The panel is headed by the ch...f a controversy over pesticide residues in colas. ...
... issue in quality of life for patients with chroni...peaker, advocate and rheumatology patient, is// ou...nals address this aspect of care. During an hour-l... experiences. Perhaps most importantly, she’ll be ...
...rs seem to have tapped nature, in the form of an e...a possible cure for a notorious type of childhood/...a accounts for nearly 3% of all cancers in childre...'Brien of the University of California, San Franci...
Other Medicine News:Health News:Making Sense of the World Through a Cochlear Implant 2Health News:Destroying Taboos to Improve Patient Care 2
(Date:12/4/2009)...ire/ -- Shared Imaging, LLC, an independent provid...ams for hospitals and healthcare providers, is exc...ion,s Accreditation for Ambulatory Health Care, a ...proval for quality and safety in patient care. Sha...obile MRI and PET/CT services. Mobile services cli...
(Date:12/4/2009)...-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP ...measures against biological and chemical threats, ...ults of a study demonstrating the effectiveness of...the New Zealand White (NZW) rabbit. The data are ...Public Health Emergency Medical Countermeasures En...
(Date:12/4/2009)...wswire/ -- Bayer Diabetes Care today announced the...r Simple Win Creativity Contest." Nick Jonas, of t...ies submitted by children with diabetes from acros...ting today with Nick. ,, The winners, who hav...om Danbury, CT, who dreams of becoming a major lea...
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Pelosi Congratulates UCSFs Elizabeth Blackburn for Receiving Nobel Prize in Medicine 58902 1The Symphony Guild Announces Artist Lineup for 2009 Event 58899 1The Symphony Guild Announces Artist Lineup for 2009 Event 58899 2The Symphony Guild Announces Artist Lineup for 2009 Event 58899 3Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT RIT Clinical Trial 14358 1Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT RIT Clinical Trial 14358 2Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT RIT Clinical Trial 14358 3
... paired-end mapping, and ge...454 Life Sciences, a Roche,company, is the subject...eek in Science, all of which employed the company,...ed "Paired-End Mapping Reveals Extensive Genomic,S...xpression Supports an,Evolutionary Link between Ma...
...eatments for Fatal Disease, CAMBRIDGE, Mass., Oct...I) today announced that it has completed the first... for ALS with the profiling of,the SOD1 mouse mode...Gehrig,s disease. The second phase, profiling of h...ary of 2008. This study is part of the,largest kno...
Other Medicine Technology:Versatility of 454 Sequencing(TM) Demonstrated in Three Publications in Science Last Week 2Versatility of 454 Sequencing(TM) Demonstrated in Three Publications in Science Last Week 3Versatility of 454 Sequencing(TM) Demonstrated in Three Publications in Science Last Week 4ALS TDI Completes Gene Expression Profile of Lou Gehrig's Disease in Mice 2ALS TDI Completes Gene Expression Profile of Lou Gehrig's Disease in Mice 3
TME 228 TS
TME 63 TC
TME 66 S
TME 64 S-3
Medicine Products: